Despite Aveanna Healthcare's recent rally, its P/S ratio remains low amid predictions its growth will lag industry standards. This suggests investor expectation of limited future growth and a reluctance to pay more for its current state, likely averting a substantial price rise soon.
Despite steady returns on capital employed, Aveanna Healthcare Holdings is not displaying potential for high growth. Market optimism should be tempered in light of current underlying trends.
アビーナ・ヘルスケア・ホールディングスに関するコメント
Can’t buy this at moomoo?
Loaded
コラムTop upgrades and downgrades on 7/5: SHOP, HPQ, CROX, NTES and more
• $アンテロ・リソーシズ(AR.US)$ : Truist Securities Upgrades to Buy from Hold - PT $50 (from $42)
• $コインベース(COIN.US)$ : US Tiger Securities Upgrades to Hold from Sell - PT $50
• $クロックス(CROX.US)$ : Loop Capital Upgrades to Buy from Hold - PT $75
• $エクセラレート・エナジー(EE.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $29
• $テキサス・インスツルメンツ(TXN.US)$ : DZ Bank Upgrades to Hold from Buy - PT $150
Downgrades
• $アビーナ・ヘルスケア・ホールディングス(AVAH.US)$ : Truist ...
コラムTop upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $ABMインダストリーズ(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $アメリカン・タワー(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $チャーチ・アンド・ドワイト(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $チューイー(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $センティーン(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
まだコメントはありません